Neuroimmunology of Traumatic Brain Injury: Time for a Paradigm Shift

Slides:



Advertisements
Similar presentations
Innate Immunity (part 1) BIOS 486A/586A
Advertisements

Cytokines Non-antibody proteins acting as mediators between cells, termed: Monokines – mononuclear phagocytes Lymphokines – activated T cells, especially.
Peter J. Barnes, FRS, FMedSci 
Mechanism of Action of Colchicine in the Treatment of Gout
Figure 3 Neutrophils in liver inflammation
Barrier Epithelial Cells and the Control of Type 2 Immunity
Inna S. Afonina, Christina Müller, Seamus J. Martin, Rudi Beyaert 
Figure 1 Radiation-induced effects on tumour cells
The inflammasome in liver disease
Therapy of autoinflammatory syndromes
Aleksandra Deczkowska, Michal Schwartz  Immunity 
Peter J. Barnes, FRS, FMedSci 
Oncology Meets Immunology: The Cancer-Immunity Cycle
Toll-like receptors: Applications to dermatologic disease
NOD-like and Toll-like receptors or inflammasomes contribute to kidney disease in a canonical and a non-canonical manner  Hans-Joachim Anders, Maciej.
The Th17 immune response in renal inflammation
The Multifaceted Role of the Intestinal Microbiota in Colon Cancer
Taking Advantage of the Systemic Immune System to Cure Brain Diseases
Toll-like receptors in Borrelia burgdorferi-induced inflammation
Toll-like receptor activation: from renal inflammation to fibrosis
Some DCs Are “B”etter Immunity
Nat. Rev. Cardiol. doi: /nrcardio
Roles for Chemokines in Liver Disease
Malaria Vaccine Design: Immunological Considerations
Zhenyu Zhong, Elsa Sanchez-Lopez, Michael Karin  Cell 
Macrophage heterogeneity, phenotypes, and roles in renal fibrosis
GM-CSF: From Growth Factor to Central Mediator of Tissue Inflammation
The Multitasking Organ: Recent Insights into Skin Immune Function
Figure 4 Macrophages in liver inflammation
Intercellular (Mis)communication in Neurodegenerative Disease
Richard L. Gallo, Jamie J. Bernard 
Benjamin L. Woolbright, Hartmut Jaeschke  Journal of Hepatology 
Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro
Joshua E. Burda, Michael V. Sofroniew  Neuron 
Jo-Ellen Murphy, Caroline Robert, Thomas S. Kupper 
Ischemia-reperfusion injury in renal transplantation: 3 key signaling pathways in tubular epithelial cells  Stephanie F. Smith, Sarah A. Hosgood, Michael.
H. Zhao, A. Alam, Q. Chen, M. A. Eusman, A. Pal, S. Eguchi, L. Wu, D
Inflammatory health effects of indoor and outdoor particulate matter
Figure 1 Principal pathogenic mechanisms of
Microbiome and Anticancer Immunosurveillance
Anti-inflammatory Agents: Present and Future
Mechanisms Underlying Inflammation in Neurodegeneration
Mechanisms of Contact Sensitization Offer Insights into the Role of Barrier Defects vs. Intrinsic Immune Abnormalities as Drivers of Atopic Dermatitis 
Macrophages in Tissue Repair, Regeneration, and Fibrosis
Inflammasomes in Intestinal Inflammation and Cancer
Myeloid Cells in the Central Nervous System
Neuroimmunology of Traumatic Brain Injury: Time for a Paradigm Shift
Therapeutic strategies in inflammasome mediated diseases of the liver
Tobias R. Kollmann, Ofer Levy, Ruth R. Montgomery, Stanislas Goriely 
Kurt M. Lucin, Tony Wyss-Coray  Neuron 
Current Challenges in Glia-Pain Biology
Rosacea: the Cytokine and Chemokine Network
Macrophage heterogeneity in liver injury and fibrosis
GM-CSF: From Growth Factor to Central Mediator of Tissue Inflammation
Mesenchymal Stromal Cells: Sensors and Switchers of Inflammation
Michael Karin, Toby Lawrence, Victor Nizet  Cell 
NODding off in acute kidney injury with progranulin?
Figure 1 The role of macrophages in RA
Inflammation 2010: New Adventures of an Old Flame
Learning Tolerance while Fighting Ignorance
Sundararaman Swaminathan, Matthew D. Griffin  Kidney International 
Sachin P. Gadani, James T. Walsh, John R. Lukens, Jonathan Kipnis 
Alternatively activated macrophages as therapeutic agents for kidney disease: in vivo stability is a key factor  Senthilkumar Alagesan, Matthew D. Griffin 
Macrophages, Immunity, and Metabolic Disease
Even Neurons Are Excited by Th17 Cells
Immunity, Inflammation, and Cancer
Peter J. Barnes, FRS, FMedSci 
Some DCs Are “B”etter Immunity
Wolbachia-induced responses of specific cell types.
Toll-like receptors, adapter proteins, and signaling molecules.
Presentation transcript:

Neuroimmunology of Traumatic Brain Injury: Time for a Paradigm Shift Yasir N. Jassam, Saef Izzy, Michael Whalen, Dorian B. McGavern, Joseph El Khoury  Neuron  Volume 95, Issue 6, Pages 1246-1265 (September 2017) DOI: 10.1016/j.neuron.2017.07.010 Copyright © 2017 Elsevier Inc. Terms and Conditions

Figure 1 Temporal Progression of the Immune Response to Contusion TBI Phase 1 begins within minutes of brain injury due to the release of alarmins from the damaged meninges, glial limitans, and parenchyma, such as ATP, HSPs, and HGMB1. These signals bind to PAMP and DAMP sensors like TLRs and purinergic receptors that induce immediate activation of resident myeloid cells (e.g., microglia) and inflammasome assembly (NALP1) that promotes the generation of mature IL-1β and IL-18. In addition, NF-κB translocates to the nuclei of these cells and induces an immunological program involving cellular proliferation and the release inflammatory amplifiers such as chemokines, cytokines, ROS, and NO, among others. Phase 1 also includes complement activation and the recruitment of neutrophils to the meninges and perivascular spaces. Neutrophil recruitment depends in part on purinergic receptor signaling. Secondary damage to CNS tissue occurs in phase 1 and can continue into phase 2. This can be mediated by inflammatory cytokines, complement, and ROS. T cells and monocytes are recruited to the damage site in phase 2, where monocytes convert into macrophages and T cells have the ability to produce neuroprotective cytokines in response to alarmins. Macrophages participate in the cleanup of debris and damaged cells. Based on their state of functional activation, they can either promote further damage or initiate the process of inflammatory resolution and tissue repair. Inflammation can continue for an extended period of time into phase 3. Self-antigens released from damaged neural cells can be presented by local antigen-presenting cells (APCs) to T cells. The ideal outcome during phase 3 is resolution of the inflammatory response, release of trophic factors, and isolation damaged areas via astrocytes. However, this is does not always occur following TBI and chronic inflammation can persist. Abbreviations: APC, antigen-presenting cell; BDNF, brain-derived neurotrophic factor; CCL2, chemokine (C-C motif) ligand 2; CXCL1, chemokine (C-X-C motif) ligand 1; CXCL2, chemokine (C-X-C motif) ligand 2; DAMP, damage associated molecular pattern molecules; HSPs, heat shock proteins; HMGB1, high mobility group box 1 protein; IGF-1, insulin-like growth factor-1; IL-1, interleukin-1; IL-4, interleukin-4; IL-10, interleukin-10; iNOS, inducible NO synthase; MyD88, myeloid differentiation primary response gene 88; NALP1, NAcht leucine-rich repeat protein 1; NT-3, neurotrophin-3; NF-κB, nuclear factor kappa-light-chain-enhancer of activated B cells; MBP, myelin basic protein; M-CSF, macrophage colony-stimulating factor; NO, nitric oxide; PAMP, pathogen-associated molecular pattern; ROS, reactive oxygen species; TGF-β, transforming growth factor beta; TLR, toll-like receptors; TNF-α, tumor necrosis factor-alpha. Neuron 2017 95, 1246-1265DOI: (10.1016/j.neuron.2017.07.010) Copyright © 2017 Elsevier Inc. Terms and Conditions

Figure 2 Acute Microglial Dynamics following Mild Focal Cortical Injury (A and B) Representative confocal images captured within the brain of a CX3CR1gfp/+ (green) mouse 3 hr following cortical injury show two microglia (red asterisks in B) extending processes (white arrowheads in B) toward the injured glial limitans (white dotted line in B) (Roth et al., 2014). Uninvolved, ramified microglia beneath the area of injury are shown in (A) for comparison. Cell nuclei are blue. (C and D) Representative time lapses captured by intravital two-photon microscopy through the thinned skull window of CX3CR1gfp/+ mice following mTBI. Time lapse (beginning 5 min post-injury) depicting the morphological transformation of ramified microglia into “honeycomb” like structures that circumscribe individual astrocytes (white asterisks) within the injured glial limitans (C). These structures provide barrier support. Convergence of phagocytic “jellyfish” microglia into an area of heavy brain damage (white dotted line in D). These cells participate in the phagocytic clearance of debris. Neuron 2017 95, 1246-1265DOI: (10.1016/j.neuron.2017.07.010) Copyright © 2017 Elsevier Inc. Terms and Conditions